Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma

Clin Exp Metastasis. 1990 Mar-Apr;8(2):215-24. doi: 10.1007/BF00117794.

Abstract

The effects of recombinant tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on B16 mouse melanoma experimental metastatic ability and major histocompatibility complex (H-2b) antigens expression were studied. B16 cells exposed in vitro to TNF-alpha had an increased H-2 expression and were more metastatic than untreated cells. The simultaneous treatment with TNF-alpha and IFN-gamma amplified the enhancement of experimental metastasis and all other effects obtained with TNF-alpha alone. The B16 clone B78H1, selectively resistant to H-2 induction and to enhancement of metastatic ability by IFN-gamma, was not affected by treatment with TNF-alpha and with TNF-alpha + IFN-gamma. These findings contribute to a better understanding of the pleiotropic effects of TNF, some of which can have opposing actions in the complex tumor-host relationships.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • H-2 Antigens / analysis
  • Interferon-gamma / pharmacology*
  • Killer Cells, Natural / drug effects
  • Male
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / pathology
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • H-2 Antigens
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma